Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Astrazeneca plc crawled date : 2022 - 05 - 16 save search
Global RSV Vaccine and Antibody Pipeline Market: Compound Annual Growth of 38.9% Forecast During 2024-2028
Published: 2022-05-16 (Crawled : 19:00) - prnewswire.com
AZNCF | $135.305 -4.19% 1.1K
|
Health Technology
|
| O: 4.22%
H: 0.0%
C: -2.05%
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: 1.08%
H: 0.0%
C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 1.5%
H: 0.64%
C: 0.19%
AZN | $68.53 0.39% 0.39% 3.7M
|
Health Technology
|
| O: 3.17%
H: 0.0%
C: 0.0%
antibody vaccine growth
Global Report on Europe precision medicine Market Size & Share Worth USD 27469 Million, to Record a 10.7% CAGR by 2028 | Europe precision medicine Industry Trends, Segmentation, Analysis & Forecast by Zion Market Research
Published: 2022-05-16 (Crawled : 17:00) - prnewswire.com
AZNCF | $135.305 -4.19% 1.1K
|
Health Technology
|
| O: 1.73%
H: 0.86%
C: -1.11%
TMO | News | $547.25 -1.32% -0.02% 1.6M
|
Health Technology
|
| O: -0.22%
H: 0.0%
C: 0.0%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: 0.0%
MDT | News | $79.08 -0.22% 0.0% 5.5M
|
Health Technology
|
| O: -0.25%
H: 2.28%
C: 1.77%
LH M | $199.97 -0.97% 0.0% 680K
|
Health Services
|
| O: -0.59%
H: 0.58%
C: -0.32%
AZN | $68.53 0.39% 0.39% 3.7M
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
europe research report market
NeoGenomics Appoints Lynn Tetrault Interim CEO
Published: 2022-05-16 (Crawled : 12:00) - biospace.com/
AZNCF | $135.305 -4.19% 1.1K
|
Health Technology
|
| O: 1.73%
H: 0.86%
C: -1.11%
NEO | $13.68 -1.23% -1.24% 560K
|
Health Services
|
| O: 13.56%
H: 1.47%
C: -6.7%
AZN | $68.53 0.39% 0.39% 3.7M
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
ceo
Proteros Expands Oncology Collaboration and License Agreement with AstraZeneca
Published: 2022-05-16 (Crawled : 11:00) - biospace.com/
AZN | $68.53 0.39% 0.39% 3.7M
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
collaboration license
Anticoagulant Reversal Drugs Market - 2022-2026 | Increasing Prevalence of Coagulation Disorders to Boost Market Growth | Technavio
Published: 2022-05-16 (Crawled : 06:00) - prnewswire.com
AZNCF | $135.305 -4.19% 1.1K
|
Health Technology
|
| O: 1.73%
H: 0.86%
C: -1.11%
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
|
| O: 1.99%
H: 0.0%
C: 0.0%
AZN | $68.53 0.39% 0.39% 3.7M
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
growth market drug
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.